SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-005863
Filing Date
2015-07-30
Accepted
2015-07-30 16:12:57
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q thld-10q_20150630.htm 10-Q 3380136
2 EX-10.1 thld-ex10_75.htm EX-10 53575
3 EX-31.1 thld-ex31_7.htm EX-31 12916
4 EX-31.2 thld-ex31_9.htm EX-31 12935
5 EX-32.1 thld-ex32_8.htm EX-32 5938
6 EX-32.2 thld-ex32_6.htm EX-32 6022
  Complete submission text file 0001564590-15-005863.txt   8444346

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT thld-20150630.xml EX-101.INS 1824898
8 XBRL TAXONOMY EXTENSION SCHEMA thld-20150630.xsd EX-101.SCH 29815
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20150630_cal.xml EX-101.CAL 36387
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20150630_def.xml EX-101.DEF 103383
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20150630_lab.xml EX-101.LAB 267304
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20150630_pre.xml EX-101.PRE 215162
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 151016314
SIC: 2834 Pharmaceutical Preparations